Stock Analysis·← Pickers

CARL

Carlsmed, Inc.

Carlsmed, Inc. (CARL) is currently in a range/mixed trend, above the 50-day MA but below the 200-day MA. RSI is at 47.9, with 1/3 trend checks passing.

Price
$11.08
2026-07-16
Trend score
1/3
Range / Mixed
RSI (14)
47.9
Neutral
Price above MA50Price above MA200MA50 above MA200
Change stock
Search another ticker to view its stock analysis page.
Chart View

CARL with MA50 and MA200

16.9914.9512.9110.878.8307/3110/2401/2204/1707/15
CARL2025-07-312026-07-15
PriceMA50MA200
Technical Indicators

Key levels & signals

MA50
$11.02+0.56% vs price
MA200
$12.00-7.65% vs price
RSI (14)
47.9Neutral zone
MACD Signal
BearishMomentum below signal
Macro Support
Not identifiedNo repeated weekly support zone found
Support Quality
Volume data unavailable
Chart Summary
Trend summary for CARL

Carlsmed, Inc. (CARL) currently looks more uncertain than directional, with a fairly mixed technical picture. The latest available price is $11.08, and 1 of 3 core trend checks are currently passing. Price is trading above the 50-day moving average by 0.6% and below the 200-day moving average by 7.6%.

Momentum and stretch context

CARL currently has an RSI reading of 47.9, which sits in a neutral range. That usually means momentum is not especially stretched in either direction, so traders may need to rely more on chart structure than on oscillator extremes alone.

What traders may watch next

This page is designed to help you quickly understand what the CARL chart looks like before opening the full dashboard. The aim is not to tell you what to buy or sell, but to make it easier to judge whether the stock is trending cleanly, becoming stretched, or simply moving in a more awkward range.

Company profile

About Carlsmed, Inc.

Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.

Sector
Healthcare
Industry
Medical - Devices
CEO
Michael Cordonnier
Employees
127
Market cap
$301.2M
Beta
2.02
52-week range
$8.50 – $17.19
Dividend
No
Exchange
NASDAQ
Country
US
IPO date
23 Jul 2025
ISIN
US14280C1053
CUSIP
14280C105
Company profile data from Financial Modeling Prep. CARL listed on NASDAQ.
Learn More

Learn the indicators behind this page

Explore More

More stock opportunities

FAQ

Common questions about CARL

Is this page a buy or sell recommendation?

No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.

Why can a stock look bullish and overbought at the same time?

Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.

What should I do next after reading this page?

Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.